Surveillance for transfusion-transmitted viral infections in the United States

Biologicals

Volumn 26, Issue 2, 1998, Pages 85-88

  Chamberland, Mary E ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD; BLOOD DONOR; BLOOD TRANSFUSION; HUMAN; INFECTION RISK; PLASMA; PRIORITY JOURNAL; RECIPIENT; RISK FACTOR; SHORT SURVEY; UNITED STATES; VIRUS INFECTION;

EID: 0031726804     PISSN: 10451056     EISSN: None     Source Type: Journal    
DOI: 10.1006/biol.1998.0137     Document Type: Article

References (15)

1. Thacker SB, Berkelman RL. Public health surveillance in the United States. Epidemiol Rev 1988; 10: 164-190.
2. Centers for Disease Control and Prevention. HIV/ AIDS Surveillance Report. 1996; 8(no. 1): 1-33.
3. Buehler JW, Berkelman RL, Stehr-Green JK. The completeness of AIDS surveillance. J Acquir Immune Defic Syndr 1992; 5: 257-264.
4. Rosenblum L. Buehler JW, Morgan MW et al. The completeness of AIDS case reporting, 1988: a multistate collaborative surveillance project. Am J Public Health 1992; 82: 1495-1499.
5. Centers for Disease Control and Prevention: National HIV Serosurveillance Summary: Results through 1992. Vol 3. Atlanta, Georgia: U.S. Department of Health and Human Services, 1994, 1-51.
6. Lacritz EM, Satten GA, Aberle-Grasse J et al. Estimated risk of transmission of the human immunodeficiency virus by screened blood in the United States. N Engl J Med 1995; 333: 1721-1725.
7. Doll LS, White CR, Petersen LR et al. Human immunodeficiency virus type 1-infected blood donors: behavioral characteristics and reasons for donation. Transfusion 1991; 31: 704-709.
8. Sullivan PS, Jones J, Schable CA et al. National surveillance for HIV-1 group O infection: Preliminary results [Abstract 159]. In: Program and Abstracts of the 4th Conference on Retro viruses and Opportunistic Infections, 22-26 January 1997, Washington, DC, 1997: 94.
9. Pau CP, Hu DJ, Spruill C et al. Surveillance for human immunodeficiency virus type 1 group O infections in the United States. Transfusion 1996; 36: 398-400.
10. Centers for Disease Control and Prevention. Hepatitis Surveillance 1995; 56: 1-33.
11. Alter MJ, Hadler SC, Margolis HS et al The changing epidemiology of hepatitis B in the United States: need for alternative vaccination strategies. JAMA 1990; 263: 1218-1222.
12. Alter MJ, Mares A, Hadler SC et al. The effect of underreporting on the apparent incidence and epidemiology of acute viral hepatitis. Am J Epidemiol 1987; 125: 133-139.
13. Holman RC, Khan AS, Belay ED et al. Creutzfeldt-Jakob Disease in the United States, 1979-1994: using national mortality data to assess the possible occurrence of variant cases. Emerg Infect Dis 1996; 2: 333-337.
14. Schonberger LB, Sullivan M, Holman RC et al. Creutzfeldt-Jakob disease (CJD) and blood safety [Abstract PW 404]. In: Abstracts of Xth International Congress of Virology, 11-16 August 1996, Jerusalem, Israel 1996: 211.
15. Centers for Disease Control and Prevention. Address-ing Emerging Infectious Disease Threats. A Prevention Strategy for the United States. Atlanta, Georgia: U.S. Department of Health and Human Services, 1994, 1-46.